CS logo
small CS logo
Fachkliniken Wangen

Wangen, Germany
Medical clinic in Baden-Württemberg
Am Vogelherd 14, 88239 Wangen im Allgäu

About Fachkliniken Wangen


"Die Fachkliniken Wangen zählen deutschlandweit zu den führenden Fach- und Spezialkliniken in der Diagnostik und Behandlung von Atemwegs- und Lungenerkrankungen, Allergien und psychosomatischen Erkrankungen sowie schwerster neurologischer Erkrankungen."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Fachkliniken Wangen


During the past decade, Fachkliniken Wangen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Fachkliniken Wangen" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Fachkliniken Wangen


According to Clinical.Site data, the most researched conditions in "Fachkliniken Wangen" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Congestive Heart Failure" (1 trials), "Heart Failure" (1 trials), "Left Ventricular Systolic Dysfunction" (1 trials) and "Sleep Disordered Breathing" (1 trials). Many other conditions were trialed in "Fachkliniken Wangen" in a lesser frequency.

Clinical Trials Intervention Types at Fachkliniken Wangen


Most popular intervention types in "Fachkliniken Wangen" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Cisplatin" (1 trials), "Erlotinib" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Fachkliniken Wangen


The vast majority of trials in "Fachkliniken Wangen" are 3 trials for "All" genders.

Clinical Trials Status at Fachkliniken Wangen


Currently, there are NaN active trials in "Fachkliniken Wangen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fachkliniken Wangen, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fachkliniken Wangen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".